Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Ltd

₹ 2,078 1.85%
19 Jun 10:37 a.m.
About

Krishna Medical Institution Ltd (KIMS) was Incorporated in the year 1973 and is one of the largest corporate healthcare groups in Andhra Pradesh and Telangana in terms of patients treated and treatments offered. The company offers multidisciplinary healthcare services with primary, secondary, and tertiary care across 2-3 tier cities and an additional quaternary healthcare facility in tier-1 cities.

Key Points

Regional Leadership
KIMS is one of the largest corporate healthcare groups in Andhra Pradesh (AP) and Telangana in terms of the number of patients treated and treatments offered. It provides multidisciplinary integrated healthcare services, with a focus on primary, secondary & tertiary care in tier 2-3 cities and primary, secondary, tertiary, and quaternary healthcare in tier 1 cities. [1]

  • Market Cap 16,628 Cr.
  • Current Price 2,078
  • High / Low 2,357 / 1,625
  • Stock P/E 53.6
  • Book Value 228
  • Dividend Yield 0.00 %
  • ROCE 16.7 %
  • ROE 17.7 %
  • Face Value 10.0

Pros

Cons

  • Stock is trading at 8.93 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company might be capitalizing the interest cost

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
359 473 412 394 372 496 564 562 576 606 652 606 634
258 330 283 264 259 358 412 411 413 449 475 459 475
Operating Profit 101 144 129 130 114 137 152 151 163 157 177 147 159
OPM % 28% 30% 31% 33% 31% 28% 27% 27% 28% 26% 27% 24% 25%
4 4 5 4 16 5 24 6 5 3 3 3 4
Interest 7 6 3 3 4 6 8 12 5 9 9 12 16
Depreciation 17 17 18 19 19 29 31 33 35 32 33 35 46
Profit before tax 81 125 113 112 107 107 137 113 127 119 139 102 100
Tax % 28% 26% 26% 25% 22% 26% 23% 27% 22% 27% 27% 25% 29%
59 92 84 84 83 79 106 82 99 87 101 77 71
EPS in Rs 7.45 11.14 10.21 10.14 10.08 8.74 12.13 9.49 11.65 10.10 11.50 8.98 8.18
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
512 567 664 918 1,123 1,330 1,651 2,198 2,498
403 450 593 833 872 953 1,126 1,598 1,858
Operating Profit 109 118 71 85 251 377 524 599 640
OPM % 21% 21% 11% 9% 22% 28% 32% 27% 26%
5 3 37 6 5 9 27 52 13
Interest 37 32 88 49 44 37 22 37 47
Depreciation 36 35 40 56 71 70 73 129 147
Profit before tax 41 53 -20 -15 141 279 457 485 460
Tax % 32% 37% -126% -223% 18% 26% 25% 25% 27%
28 33 -46 -49 115 205 344 366 336
EPS in Rs 3.78 4.55 -6.61 -6.40 16.00 25.93 41.57 42.03 38.76
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 22%
3 Years: 23%
TTM: 14%
Compounded Profit Growth
10 Years: %
5 Years: 53%
3 Years: 15%
TTM: -5%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 19%
Return on Equity
10 Years: %
5 Years: 23%
3 Years: 22%
Last Year: 18%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 70 72 50 74 74 78 80 80 80
Reserves 193 255 -209 466 523 786 1,307 1,590 1,748
256 280 753 336 369 316 257 678 1,355
146 167 359 237 228 253 260 553 668
Total Liabilities 665 774 954 1,114 1,194 1,433 1,904 2,901 3,852
515 518 755 863 916 931 1,005 1,766 2,434
CWIP 2 64 0 0 2 9 21 477 600
Investments 11 14 0 0 0 0 332 68 157
137 177 199 250 276 493 546 590 661
Total Assets 665 774 954 1,114 1,194 1,433 1,904 2,901 3,852

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
95 82 106 134 202 356 324 432 521
-41 -100 -64 -110 -125 -354 -412 -484 -753
-65 24 -39 -27 -44 10 61 88 217
Net Cash Flow -11 5 3 -3 32 12 -26 36 -15

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 47 59 59 49 43 30 28 42 43
Inventory Days 36 43 46 47 44 30 37 33 34
Days Payable 194 207 215 181 177 167 133 132 136
Cash Conversion Cycle -111 -105 -110 -85 -91 -106 -67 -58 -59
Working Capital Days 11 26 -315 -7 -10 -6 4 15 26
ROCE % 15% 11% 5% 20% 29% 34% 24%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
38.84% 38.84% 38.84% 38.84% 38.84% 38.85% 38.85% 38.85% 38.85% 38.85% 38.82% 38.82%
11.57% 9.90% 8.44% 8.91% 8.36% 10.17% 20.50% 19.41% 13.15% 14.24% 15.27% 16.73%
16.28% 18.64% 20.87% 21.02% 22.78% 27.97% 28.32% 29.76% 35.77% 34.80% 34.24% 33.13%
33.31% 32.61% 31.84% 31.23% 30.01% 23.01% 12.34% 11.99% 12.23% 12.10% 11.67% 11.32%
No. of Shareholders 1,03,05786,38974,35573,66470,79567,73563,36260,98065,44966,95771,01469,092

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls